Cadence Pharmaceuticals to Present at Two Investment Conferences in February 2011

News provided by

Feb 08, 2011, 04:00 ET

SAN DIEGO, Feb. 8, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company will present a corporate overview at the following investment conferences in February:

BIO CEO & Investor Conference
	Date:	Tuesday, February 15, 2011
	Time:	9:00am Eastern Time (6:00am Pacific Time)
	Place:	Waldorf Astoria Hotel in New York City
	Speaker:	Ted Schroeder, President & CEO

Leerink Swann Hot Topics Roundtable Conference
	Date:	Thursday, February 17, 2011
	Time:	10:05am Eastern Time (7:05am Pacific Time)
	Place:	Roosevelt Hotel in New York City
	Speaker:	Ted Schroeder, President & CEO

Each presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com on the Investor Relations page. A replay of each webcast will available approximately three hours after the live webcast concludes and will remain available for 30 days.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. For more information about Cadence, visit www.cadencepharm.com.